SYNERGISTIC ANTITUMOR INTERACTIONS BETWEEN PANOBINOSTAT AND CONVENTIONAL CHEMOTHERAPY DRUGS IN HIGH-RISK NEUROBLASTOMA

被引：0
|
作者：
Wang, G. [1 ]
Jolly, P. [2 ]
Taub, J. [1 ]
Ge, Y. [2 ]
Wang, Z. [1 ]
机构：
[1] Wayne State Univ, Childrens Hosp Michigan, Detroit, MI USA
[2] Wayne State Univ, Karmanos Canc Ctr, Detroit, MI USA
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：120 / 121
页数：2
相关论文
共 50 条
  • [41] Eflornithine for treatment of high-risk neuroblastoma
    Jiang, Jianxiong
    Yu, Ying
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (06) : 577 - 578
  • [42] Dinutuximab: A Review in High-Risk Neuroblastoma
    Hoy, Sheridan M.
    TARGETED ONCOLOGY, 2016, 11 (02) : 247 - 253
  • [43] A Safer Regimen for High-Risk Neuroblastoma
    Felix, Carolyn A.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (01) : 3 - 6
  • [44] Immunocombination therapy for high-risk neuroblastoma
    Kroesen, Michiel
    Lindau, Dennis
    Hoogerbrugge, Peter
    Adema, Gosse J.
    IMMUNOTHERAPY, 2012, 4 (02) : 163 - 174
  • [45] Rethinking high-risk neuroblastoma treatment
    Cohn, Susan L.
    Pearson, Andrew D. J.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [46] The genetic landscape of high-risk neuroblastoma
    Pugh, Trevor J.
    Morozova, Olena
    Attiyeh, Edward F.
    Asgharzadeh, Shahab
    Wei, Jun S.
    Auclair, Daniel
    Carter, Scott L.
    Cibulskis, Kristian
    Hanna, Megan
    Kiezun, Adam
    Kim, Jaegil
    Lawrence, Michael S.
    Lichenstein, Lee
    McKenna, Aaron
    Pedamallu, Chandra Sekhar
    Ramos, Alex H.
    Shefler, Erica
    Sivachenko, Andrey
    Sougnez, Carrie
    Stewart, Chip
    Ally, Adrian
    Birol, Inanc
    Chiu, Readman
    Corbett, Richard D.
    Hirst, Martin
    Jackman, Shaun D.
    Kamoh, Baljit
    Khodabakshi, Alireza Hadj
    Krzywinski, Martin
    Lo, Allan
    Moore, Richard A.
    Mungall, Karen L.
    Qian, Jenny
    Tam, Angela
    Thiessen, Nina
    Zhao, Yongjun
    Cole, Kristina A.
    Diamond, Maura
    Diskin, Sharon J.
    Mosse, Yael P.
    Wood, Andrew C.
    Ji, Lingyun
    Sposto, Richard
    Badgett, Thomas
    London, Wendy B.
    Moyer, Yvonne
    Gastier-Foster, Julie M.
    Smith, Malcolm A.
    Auvil, Jaime M. Guidry
    Gerhard, Daniela S.
    NATURE GENETICS, 2013, 45 (03) : 279 - 284
  • [47] Outcome of children with high-risk neuroblastoma
    Fluchel, M
    Hawkins, DS
    Felgenhauer, J
    Douglas, JJ
    Sanders, JE
    Park, JR
    PEDIATRIC RESEARCH, 2003, 53 (04) : 300A - 301A
  • [48] The Role of Surgery in High-risk Neuroblastoma
    Ryan, Anne L.
    Akinkuotu, Adesola
    Pierro, Agostino
    Morgenstern, Daniel A.
    Irwin, Meredith S.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (01) : 1 - 7
  • [49] Evolving treatments in high-risk neuroblastoma
    Kumar, Abhinav
    Rocke, John P. J.
    Kumar, B. Nirmal
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (12): : 497 - 506
  • [50] The Influence of Sarcopenia on High-Risk Neuroblastoma
    Kawakubo, Naonori
    Kinoshita, Yoshiaki
    Souzaki, Ryota
    Koga, Yuhki
    Oba, Utako
    Ohga, Shouichi
    Taguchi, Tomoaki
    JOURNAL OF SURGICAL RESEARCH, 2019, 236 : 101 - 105
12345